def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to §240.14a-12 |
UNIVERSAL DISPLAY CORPORATION
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined): |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
UNIVERSAL
DISPLAY CORPORATION
375 Phillips Boulevard
Ewing, New Jersey 08618
NOTICE OF 2007 ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD JUNE 21, 2007
Dear Shareholders:
You are cordially invited to attend our 2007 Annual Meeting of
Shareholders on Thursday, June 21, 2007, at 4:00 p.m.,
Eastern Time, at the Holiday Inn City Line Avenue,
4100 Presidential Boulevard, Philadelphia, Pennsylvania 19131.
We are holding the meeting to:
|
|
|
|
(1)
|
Elect seven members of our Board of Directors to hold one-year
terms;
|
|
|
(2)
|
Consider and vote on a proposal to ratify the appointment of
KPMG LLP as the Companys independent registered public
accounting firm for 2007; and
|
|
|
(3)
|
Transact any other business that may properly come before the
shareholders at the meeting.
|
If you were the record owner of shares of our common stock at
the close of business on April 13, 2007, you may attend and
vote at the meeting. If you cannot attend the meeting, you may
vote by returning the enclosed proxy card or, if you hold your
shares in street name, the enclosed voting
instruction form. Any shareholder of record may vote in person
at the meeting, even if he or she has already returned a proxy
card. A list of all shareholders of record will be made
available for review by registered shareholders both at the
meeting and, during regular business hours, at our headquarters
in Ewing, New Jersey for 10 days prior to the meeting.
We look forward to seeing you at the meeting.
Sincerely,
Sidney D. Rosenblatt
Executive Vice President, Chief Financial Officer,
Treasurer and Secretary
Ewing, New Jersey
April 27, 2007
As promptly as possible, please complete, sign, date and
return the enclosed proxy card or voting instruction form in the
postage-paid return envelope provided. Please fill out and
return the proxy card or instruction form whether or not you
expect to attend the annual meeting in person. If you are a
shareholder of record and you attend the meeting in person, you
may revoke your proxy and vote your shares at that time.
UNIVERSAL
DISPLAY CORPORATION
375 Phillips Boulevard
Ewing, New Jersey 08618
PROXY
STATEMENT FOR 2007 ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD JUNE 21, 2007
INFORMATION
CONCERNING THIS SOLICITATION
The Board of Directors of Universal Display Corporation (we, us
or the Company) is soliciting proxies for the 2007
Annual Meeting of Shareholders to be held on Thursday,
June 21, 2007, at 4:00 p.m., Eastern Time, at the
Holiday Inn City Line Avenue, 4100 Presidential
Boulevard, Philadelphia, Pennsylvania 19131 (the Annual
Meeting). This proxy statement contains important
information for shareholders to consider when deciding how to
vote on the matters brought before the Annual Meeting. Please
read it carefully.
At the Annual Meeting, our shareholders will be asked to vote
upon:
|
|
|
|
(1)
|
the election of seven members of our Board of Directors to hold
one-year terms;
|
|
|
(2)
|
a proposal to ratify the appointment of KPMG LLP as the
Companys independent registered public accounting firm
(our independent auditors) for 2007; and
|
|
|
(3)
|
such other business as may properly come before the shareholders
at the Annual Meeting.
|
Voting materials, which include the proxy statement, a proxy
card and our Annual Report for 2006, will be mailed to all
registered shareholders beginning on or about April 27,
2007. Shareholders holding their shares in street
name should receive the proxy statement and a voting
instruction form from their broker, bank or other custodian,
nominee or fiduciary. We will pay the expenses of these
solicitations. In addition to solicitation by mail, proxies may
be solicited by telephone or in person by some of our officers,
directors and regular employees or independent contractors who
will not be specially engaged or compensated for such services.
Our principal executive offices are located at 375 Phillips
Boulevard, Ewing, New Jersey 08618. Our general telephone number
is
(609) 671-0980.
VOTING AT
THE ANNUAL MEETING
Our Board of Directors has set April 13, 2007 as the record
date for the Annual Meeting (the Record Date). As of
the Record Date, we had outstanding 31,706,385 shares of
common stock and 200,000 shares of Series A
Nonconvertible Preferred Stock. Each holder of our common stock
or Series A Nonconvertible Preferred Stock is entitled to
one vote per share on all matters to be voted on at the Annual
Meeting. Holders of our common stock and Series A
Nonconvertible Preferred Stock vote together as a single class
on all matters.
Only shareholders of record as of the close of business on the
Record Date may attend and vote at the Annual Meeting. The
presence, in person or by proxy, of shareholders entitled to
cast at least a majority of the votes that all shareholders are
entitled to cast on a particular matter to be acted upon at the
Annual Meeting will constitute a quorum for purposes of that
matter. Shareholders of record who return a proxy card but
abstain from voting or fail to vote on a particular matter will
be considered present for quorum purposes with
respect to the matter. In addition, shares held by brokers or
nominees who have notified us on a proxy card or otherwise in
accordance with industry practice that they have not received
voting instructions with respect to a particular matter and that
they lack or have declined to exercise voting authority with
respect to such matter (referred to in this proxy statement as
uninstructed shares), will be considered
present for quorum purposes with respect to the
matter.
Votes not cast by brokers or nominees with respect to
uninstructed shares are referred to in this proxy statement as
broker non-votes.
The persons named in the enclosed proxy will vote the shares
represented by each properly executed proxy as directed therein.
In the absence of such direction on a properly executed proxy
card, the persons named in the enclosed proxy will vote
FOR the persons nominated by our Board of Directors
for election as directors and
FOR the proposal to ratify KPMG LLP as our
independent auditors. As to other items of business that may
properly be presented at the Annual Meeting for action, the
persons named in the enclosed proxy will vote the shares
represented by the proxy in accordance with their best judgment.
A shareholder of record may revoke his or her proxy at any time
before its exercise by giving written notice of such revocation
to our Corporate Secretary. In addition, any shareholder of
record may vote by ballot at the Annual Meeting, even if he or
she has already returned a proxy card.
The preliminary voting results will be announced at the Annual
Meeting. The final results will be published in our quarterly
report on
Form 10-Q
for the quarter ending June 30, 2007.
Your vote is important. Please complete, sign and return the
accompanying proxy card or voting instruction form whether or
not you plan to attend the Annual Meeting. If you plan to attend
the Annual Meeting to vote in person and your shares are
registered with our transfer agent in the name of a broker, bank
or other custodian, nominee or fiduciary, you must secure a
proxy from that person or entity assigning you the right to vote
your shares of common stock.
2
PROPOSAL 1
ELECTION OF DIRECTORS
Our Board of Directors has fixed the number of directors at
seven, all of whom are to be elected at the Annual Meeting. Each
director elected will serve until our next annual meeting of
shareholders and such time as a successor has been selected and
qualified, or until the directors earlier death,
resignation or removal. Each nominee has consented to being
nominated and to serve if elected. If any nominee should
subsequently decline or be unable to serve, the persons named in
the proxy will vote for the election of such substitute nominee
as shall be determined by them in accordance with their best
judgment.
Pursuant to our Amended and Restated Articles of Incorporation,
the holder of our Series A Nonconvertible Preferred Stock
is entitled to nominate and elect two of the members of our
Board of Directors. The holder of the Series A
Nonconvertible Preferred Stock has waived this right with
respect to the election of directors at the Annual Meeting.
All nominees are presently members of our Board of Directors
whose terms expire at the Annual Meeting. The nominees for
election are as follows:
NOMINEES
FOR ELECTION AS DIRECTORS
|
|
|
|
|
|
|
|
|
|
|
Year First Became Director,
|
Name of Director
|
|
Age
|
|
Principal Occupations and Certain Directorships
|
|
Sherwin I. Seligsohn
|
|
|
71
|
|
|
Mr. Seligsohn has been our Chief
Executive Officer and Chairman of our Board of Directors since
June 1995. He also served as our President from June 1995
through May 1996. Mr. Seligsohn founded and since has
served as the sole Director, President and Secretary of American
Biomimetics Corporation, International Multi-Media Corporation,
and Wireless Unified Network Systems Corporation. He is also
Chairman of the Board of Directors and Chief Executive Officer
of Global Photonic Energy Corporation. From June 1990 to October
1991, Mr. Seligsohn was Chairman Emeritus of InterDigital
Communications, Inc. (InterDigital), formerly International
Mobile Machines Corporation. He founded InterDigital and from
August 1972 to June 1990 served as its Chairman of the Board of
Directors. Mr. Seligsohn is a member of the Industrial
Advisory Board of the Princeton Institute for the Science and
Technology of Materials (PRISM) at Princeton University.
|
Steven V. Abramson
|
|
|
55
|
|
|
Mr. Abramson has been our
President and Chief Operating Officer and a member of our Board
of Directors since May 1996. From March 1992 to May 1996, he was
Vice President, General Counsel, Secretary and Treasurer of Roy
F. Weston, Inc., a worldwide environmental consulting and
engineering firm. From December 1982 to December 1991,
Mr. Abramson held various positions at InterDigital,
including General Counsel, Executive Vice President and General
Manager of the Technology Licensing Division. Mr. Abramson
is a member of the Executive Committee of PRISM and is also on
the Executive Committee of the Board of Governors of the United
States Display Consortium.
|
Sidney D. Rosenblatt
|
|
|
59
|
|
|
Mr. Rosenblatt has been our
Executive Vice President, Chief Financial Officer, Treasurer and
Secretary since June 1995, and has been a member of our Board of
Directors since May 1996. Mr. Rosenblatt is the owner of
and served as the President of S. Zitner Company from August
1990 through December 1998. From May 1982 to August 1990,
Mr. Rosenblatt served as the Senior Vice President, Chief
Financial Officer and Treasurer of InterDigital.
|
3
|
|
|
|
|
|
|
|
|
|
|
Year First Became Director,
|
Name of Director
|
|
Age
|
|
Principal Occupations and Certain Directorships
|
|
Leonard Becker
|
|
|
83
|
|
|
Mr. Becker has been a member of
our Board of Directors since February 2001. For the last
40 years, Mr. Becker has been a general partner of
Becker Associates, which is engaged in real estate investments
and management. He previously served on the Board of Directors
of American Business Financial Services, Inc. (OTCBB:
ABFIQ.PK), as well as on its compensation and
audit committees. He also previously served as a director of
Eagle National Bank and Cabot Medical Corporation.
|
Elizabeth H. Gemmill
|
|
|
61
|
|
|
Ms. Gemmill has been a member of
our Board of Directors since April 1997. Since March 1999, she
has been Managing Trustee and, more recently, President of the
Warwick Foundation. From February 1988 to March 1999,
Ms. Gemmill was Vice President and Secretary of Tasty
Baking Company. Ms. Gemmill is Chairman of the Board of
Philadelphia University and serves on the Boards of Directors of
Philadelphia Consolidated Holdings Corporation
(Nasdaq: PHLY), Beneficial Savings Bank MHC,
the Philadelphia College of Osteopathic Medicine, and the YMCA
of Philadelphia and Vicinity. She previously served as a
director of American Water Works Company, Inc.
(NYSE: AWK) until it was sold in early 2003.
|
C. Keith Hartley
|
|
|
64
|
|
|
Mr. Hartley has been a member of
our Board of Directors since September 2000. Since June 2000, he
has been the President of Hartley Capital Advisors, a merchant
banking firm. From August 1995 to May 2000, he was the managing
partner of Forum Capital Markets LLC, an investment banking
company. In the past, Mr. Hartley held the position of
managing partner for Peers & Co. and Drexel Burnham
Lambert, Inc. He also serves as a director of Idera
Pharmaceuticals, Inc. (AMEX: IDP) and Swisher
International Group, Inc.
|
Lawrence Lacerte
|
|
|
54
|
|
|
Mr. Lacerte has been a member of
our Board of Directors since October 1999. Since July 1998, he
has been Chairman of the Board of Directors and Chief Executive
Officer of Lacerte Technology Inc., a company specializing in
technology and Internet-related ventures. Prior to that time, he
was the founder, Chairman of the Board of Directors and Chief
Executive Officer of Lacerte Software Corp., which was sold to
Intuit Corporation in June 1998.
|
Vote Required and Recommendation of our Board of Directors
Directors are elected by a plurality and the seven nominees who
receive the most votes will be elected. Shareholders may vote
for or withhold their vote from each nominee, or the entire
group of nominees as a whole. Broker non-votes are not
considered votes cast with respect to this proposal
and will have no effect on the outcome of the election of
directors. Shareholders do not have cumulative voting rights
with regard to the election of members of our Board of Directors.
THE BOARD
OF DIRECTORS RECOMMENDS A VOTE FOR
EACH OF THE NOMINEES FOR DIRECTOR.
Director Independence
Our Board of Directors has determined that a majority of its
members are independent directors within the meaning
of applicable NASDAQ listing requirements. Our independent
directors are Mr. Becker, Ms. Gemmill,
Mr. Hartley and Mr. Lacerte. In addition, based on
these listing requirements, our Board of Directors has
determined that Mr. Seligsohn, Mr. Abramson and
Mr. Rosenblatt are not independent directors because they
are all officers of the Company.
4
Our independent directors meet in executive session on a
periodic basis in connection with regularly-scheduled meetings
of the full Board of Directors, as well as in their capacity as
members of our Audit Committee and Compensation Committee.
Board
Meetings and Committees; Annual Meeting Attendance
Our Board of Directors held seven meetings during 2006, and each
incumbent director attended all of these meetings. Our Audit
Committee and Compensation Committee each held four meetings
during 2006, and each member of these committee attended all of
these meetings.
All incumbent directors and nominees for election as director
are encouraged, but not required, to attend our annual meetings
of shareholders. All but one of the current members of our Board
of Directors attended our annual meeting of shareholders in 2006.
Director
Nominations
Our Board of Directors has not established a standing committee
to nominate candidates for election as directors. Instead, a
majority of our independent directors recommend, and our full
Board of Directors selects, the candidates that will be
nominated to stand for election as directors at our annual
meetings of shareholders. Our Board of Directors believes that
this process is appropriate given the relatively small size of
our Board of Directors and the fact that each independent
director already serves on both the Audit Committee and the
Compensation Committee. Since we do not have a nominating
committee, our Board of Directors has not adopted a nominating
committee charter.
In nominating candidates for election as directors, both our
independent directors and our full Board of Directors consider
the skills, experience, character, commitment and diversity of
background of each potential nominee, all in the context of the
requirements of our Board of Directors at that point in time.
Each candidate should be an individual who has demonstrated
integrity and ethics, has an understanding of the elements
relevant to the success of a publicly-traded company, and has
established a record of professional accomplishment in such
candidates chosen field. Each candidate also should be
prepared to participate in all Board and committee meetings that
he or she attends, and should not have other personal or
professional commitments that might reasonably be expected to
interfere with or limit such candidates ability to do so.
Additionally, in determining whether to recommend a director for
re-election, the directors past attendance at Board and
committee meetings should be considered.
Our Board of Directors has no stated specific, minimum
qualifications that must be met by candidates for election as
directors. However, in accordance with SEC rules and applicable
NASDAQ listing requirements, at least one member of our Board of
Directors is expected to meet the criteria for an audit
committee financial expert as defined by SEC rules, and a
majority of the members of the Board are expected to meet the
definition of independent director within the
meaning of SEC rules and applicable NASDAQ listing requirements.
Any shareholder of record entitled to vote in the election of
directors at an annual or special meeting of our shareholders
may nominate one or more persons to stand for election to the
Board at such meeting in accordance with the requirements of our
Amended and Restated Bylaws. In order to be considered by our
Board of Directors in connection with the nominations process
for our 2008 annual meeting of shareholders, all such director
nominations must be received by our Corporate Secretary at our
principal executive offices by February 22, 2008. Each such
submission must be in writing and must comply with the notice,
information and consent provisions contained in our Amended and
Restated Bylaws. In addition, each such submission must include
any other information required by Regulation 14A under the
Securities Exchange Act of 1934, as amended (the Exchange
Act). Submissions should be addressed to our Corporate
Secretary at the following address: Universal Display
Corporation, 375 Phillips Boulevard, Ewing, New Jersey
08618.
Our independent directors and the full Board of Directors will
consider all candidates identified by shareholders through the
processes described above, and will evaluate each of them,
including incumbent directors, based on the same criteria.
Although we have no formal policy regarding shareholder
nominees, our Board of Directors believes that shareholder
nominees should be viewed in substantially the same manner as
other nominees.
5
The consideration of any candidate for director will be based on
an assessment of the individuals background, skills and
abilities, together with an assessment of whether such
characteristics qualify the individual to fulfill the needs of
our Board of Directors at that time.
Audit
Committee
Our Board of Directors has established a standing Audit
Committee. The members of our Audit Committee are
Mr. Becker, Ms. Gemmill, Mr. Hartley and
Mr. Lacerte. Ms. Gemmill is the Chairperson of our
Audit Committee.
Our Audit Committee operates pursuant to a written charter that
complies with the applicable provisions of the Sarbanes-Oxley
Act of 2002 and related rules of the Securities and Exchange
Commission (the SEC) and NASDAQ listing standards.
The Audit Committee Charter was updated by our Board of
Directors on April 18, 2006, and a copy of the updated
charter is publicly available through the For
Investors section of our website at
http://www.universaldisplay.com.
According to its charter, our Audit Committee is responsible
for, among other things:
|
|
|
|
|
reviewing our financial statements and discussing with
management and our independent auditor these statements and
other relevant financial matters;
|
|
|
|
selecting and evaluating our independent auditor and approving
all audit engagement fees and terms;
|
|
|
|
pre-approving all audit and non-audit services provided to us,
including the scope of such services, the procedures to be
utilized and the compensation to be paid;
|
|
|
|
assessing the effectiveness of our internal control system and
discussing this assessment with management and our independent
auditor;
|
|
|
|
reviewing our financial reporting and accounting standards and
principles, significant changes in these standards and
principles, or in their application, and key accounting
decisions affecting our financial statements, including
alternatives to, and the rationale for, these decisions;
|
|
|
|
discussing with management and our independent auditor, as
appropriate, our risk assessment and risk management policies,
including our major exposures to financial risk and the steps
taken by management to monitor and mitigate these
exposures; and
|
|
|
|
reviewing and investigating any matters pertaining to the
integrity of management, including any actual or potential
conflicts of interest or allegations of fraud, and the adherence
of management to our standards of business conduct.
|
Each member of our Audit Committee meets the financial knowledge
and independence criteria of the NASDAQ listing requirements.
Our Board of Directors has determined that Ms. Gemmill is
an audit committee financial expert as such term is
defined under SEC regulations, and that Ms. Gemmill meets
the financial sophistication and independence standards mandated
by the NASDAQ listing requirements.
6
Report
of the Audit Committee
The Audit Committee has reviewed and discussed with Company
management the audited financial statements of the Company for
the fiscal year ended December 31, 2006, as well as
managements assessment of the Companys internal
control over financial reporting as of December 31, 2006.
In addition, the Audit Committee has discussed with the
Companys independent auditor, KPMG LLP, the matters
required to be discussed by Statement on Auditing Standards
No. 61 (Codification of Statements on Auditing Standards,
AU § 380), as may be modified or supplemented, and the
matters required by auditing standards of the Public Company
Accounting Oversight Board (PCAOB), including the opinions
regarding internal control over financial reporting pursuant to
PCAOB Auditing Standard No. 2. The Audit Committee also has
received the written disclosures and the letter from KPMG LLP
required by Independence Standards Board Standard No. 1
(Independence Discussions with Audit Committees), and has
discussed the independence of KPMG LLP with that firm. Based on
the Audit Committees review of the matters noted above and
its discussions with management and the Companys
independent auditor, the Audit Committee recommended to the
Companys Board of Directors that the audited financial
statements be included in the Companys Annual Report on
Form 10-K
for the period ended December 31, 2006.
Respectfully submitted by the Audit Committee
Elizabeth H. Gemmill (Chairperson)
Leonard Becker
C. Keith Hartley
Lawrence Lacerte
Compensation
Committee
Our Board of Directors has established a standing Compensation
Committee. The members of our Compensation Committee are
Mr. Becker, Ms. Gemmill, Mr. Hartley and
Mr. Lacerte. Ms. Gemmill is the Chairperson of our
Compensation Committee.
Our Compensation Committee, which does not operate pursuant to a
written charter, is responsible for, among other things:
|
|
|
|
|
recommending to the full Board of Directors the base salary,
incentive compensation and any other compensation for the
Companys Chief Executive Officer, Chief Operating Officer,
Chief Financial Officer and Chief Technical Officer;
|
|
|
|
recommending to the full Board of Directors the compensation for
service as a member of the Board of Directors or any Board
committees;
|
|
|
|
reviewing and approving or ratifying managements
recommendations for equity compensation awards to other
employees and consultants of the Company;
|
|
|
|
administering and discharging the duties imposed on the
Committee under the terms of the Companys Equity
Compensation Plan; and
|
|
|
|
performing such other functions and duties as are deemed
appropriate by the full Board of Directors.
|
Our Compensation Committee has historically determined the
compensation for the Companys executive officers in two
stages. Base salary adjustments and perquisites and other
benefits (life insurance coverage, automobile allowance, etc.)
have been approved mid-year, to coincide with the annual
employment anniversaries of these individuals with the Company.
Annual bonus awards, long-term incentive awards, and special
cash and non-cash awards have been granted at or shortly after
year-end. This enables the Committee to review the
Companys fiscal performance for the year in determining
these grants.
Our Compensation Committee has historically determined the
compensation for members of the Companys Board of
Directors at year-end. For 2007, however, the Committee set
compensation for Board members in advance, with this
compensation being payable in quarterly installments. No
separate compensation is awarded for
7
committee service, and directors who are employees or officers
of the Company do not receive separate compensation for their
service on the Board.
Company management recommends to the Compensation Committee
compensation for all of the Companys employees, including
its executive officers and directors, in order to facilitate the
Committees activities. However, the Committee exercises
independent judgment in making its determinations of
compensation for executive officers and directors, and in
recommending this compensation to the full Board of Directors.
This includes meetings of the Committee in executive session to
review and ultimately finalize its recommendations.
Compensation
Committee Interlocks and Insider Participation
Each member of our Compensation Committee is an independent
director under the NASDAQ listing requirements. None of the
members of our Compensation Committee were officers or employees
of the Company or its subsidiary during 2006, were formerly
officers of the Company or its subsidiary, or had any
relationship with the Company since the beginning of 2006 that
requires disclosure under Item 404 of
Regulation S-K.
Nor have there been, since the beginning of 2006, any
compensation committee interlocks involving our directors and
executive officers that require disclosure under Item 407
of
Regulation S-K.
Report
of the Compensation Committee
The Compensation Committee of the Company has reviewed and
discussed the Compensation Discussion and Analysis required by
Item 402(b) of
Regulation S-K
with management and, based on such review and discussions, the
Compensation Committee recommended to the Board that the
Compensation Discussion and Analysis be included in this Proxy
Statement.
Respectfully submitted by the Compensation Committee
Elizabeth H. Gemmill (Chairperson)
Leonard Becker
C. Keith Hartley
Lawrence Lacerte
Shareholder
Communications
Shareholders may send communications to our Board of Directors,
or to individual members of our Board of Directors, care of our
Corporate Secretary at the following address: Universal Display
Corporation, 375 Phillips Boulevard, Ewing, New Jersey 08618. In
general, all shareholder communications sent to our Corporate
Secretary for forwarding to our Board of Directors, or to
specified Board members, will be forwarded in accordance with
the senders instructions. However, our Corporate Secretary
reserves the right to not forward to members of our Board of
Directors any abusive, threatening or otherwise inappropriate
materials. Information on how to submit complaints to our Audit
Committee regarding accounting, internal accounting controls or
auditing matters can be found on the For Investors
section of our website at
http://www.universaldisplay.com. The information on our
website referenced in this proxy statement is not and should not
be considered a part of this proxy statement.
EXECUTIVE
COMPENSATION
Compensation
Discussion and Analysis
Compensation
Philosophy and Objectives
Compensation and benefits programs are an important part of our
relationship with our employees. We seek to reward individuals
for individual accomplishments and contributions to our
long-term strategic and short-term business goals. Our
compensation and benefits packages are intended to be
competitive, thereby allowing us to attract, motivate and retain
talented employees. We also attempt to link the business goals
of our executive officers
8
with the interests of our shareholders, by linking a significant
portion of their compensation to the value of our common stock.
How We
Determine Executive Compensation
Each year, Company management and our Compensation Committee
review all components of compensation to our executive officers,
factoring in both recent historical compensation and near-term
prospective compensation. This analysis takes into account the
extent to which we have achieved our business goals, including
our goals for revenues, expense management, balance sheet
stability, research and development, the further development of
existing business relationships, the creation of new strategic
relationships and increased shareholder value. We also evaluate
the individual performance of our executive officers in relation
to the achievement of these goals, as well as relative pay
considerations within the executive officer group.
We strive to provide competitive compensation while offering
programs that emphasize our key goals of rewarding performance
and encouraging retention of key talent. To achieve these goals,
compensation paid to our executives is structured to ensure that
there is an appropriate balance between: (i) long-term and
short-term performance-based compensation; (ii) cash and
non-cash forms of compensation; (iii) the different forms
of equity-based and other non-cash compensation;
(iv) individual performance, Company performance and
shareholder value; and (v) cost and expected near-term and
long-term benefit to the Company. While we consider publicly
available compensation information regarding other comparable
companies, we do not engage in benchmarking of compensation.
Executive management makes recommendations to our Compensation
Committee regarding all aspects of our compensation programs.
However, final decisions on any major element of compensation,
as well as total compensation for our executive officers, are
made by our Compensation Committee. Awards to our executive
officers are recommended by our Compensation Committee and
approved by our Board of Directors at previously scheduled
meetings. Our Chief Executive Officer does not participate in
Compensation Committee or Board deliberations regarding his
compensation. Also, our Compensation Committee does not set
equity grant dates in order to affect the value of any award.
Elements
of Compensation
Our total compensation program for executive officers consists
of the following elements:
|
|
|
|
|
Base salaries;
|
|
|
|
Annual bonus awards;
|
|
|
|
Long-term equity compensation awards;
|
|
|
|
Special cash and non-cash awards; and
|
|
|
|
Perquisites and other benefits.
|
Base salaries
Consistent with our overall compensation philosophy, we believe
that competitive base salaries help attract, motivate and retain
good performers. Base salaries are intended to be generally
competitive with those offered by other comparable companies,
taking into account such factors as the level of responsibility
involved, the need for special expertise and the specific
individuals experience and prior performance at the
Company.
Based on historical practice, at a meeting held during the
second or third quarter of each year, the base salaries of
Mr. Seligsohn, Mr. Abramson and Mr. Rosenblatt
are adjusted effective as of July 1st of that year,
and the salary of Dr. Brown is adjusted effective as of
June 22 of that year. Consistent with the range of salary
increases for all of our employees, the base salaries for our
executive officers were increased by five and one-half percent
(5.5%) in 2006. We believe that these increases, as well as the
overall base salaries of our executive officers, are reasonable
and appropriate under current market conditions.
9
Annual bonus awards
Bonuses have historically been awarded to employees on an
annual basis. These bonus awards have included both cash and
non-cash compensation, with non-cash compensation taking the
form of vested shares of our common stock. These awards are
based on individual and Company performance as measured both
qualitatively and quantitatively. We believe that using common
stock to pay these awards aligns employee interests with those
of our shareholders.
Our Compensation Committee instituted an Executive Performance
Compensation Program for the Companys executive officers
in 2004. This program, which runs through 2007, contemplates
that executive management bonus compensation would be awarded
based substantially on the achievement of performance goals to
be set annually by the Compensation Committee for each
individual executive officer. These goals and the awards for
achieving them were to be established in a manner designed to
reward enhanced Company and individual performance of both a
qualitative and quantitative nature. Specific metrics for
quantitative assessment were to include, for example, items such
as revenues, earnings, expense management, stock price and
number of new contracts executed.
The Committee, however, did not set formal performance goals and
corresponding awards for the Companys executive officers
for 2005 or 2006. Pursuant to its authority, the Committee
determined that bonus compensation to executive officers for
these years would be granted by the Committee in its discretion,
taking into account the Companys financial results,
business performance and other relevant factors, at year-end.
The Committee concluded that this approach was appropriate in
light of the early stage of the market for commercial OLED
products.
Bonus awards to our executive officers for 2006 were determined
by our Compensation Committee in its discretion at a meeting
held on January 9, 2007. These awards took the form of
shares of our common stock issued as follows:
Mr. Seligsohn 13,689 shares;
Mr. Abramson 23,956 shares;
Mr. Rosenblatt 23,956 shares and
Dr. Brown 13,689 shares. These awards were
designed to recognize the substantial efforts of our executive
officers to position the Company for the future, particularly in
light of delays in the launch of commercial OLED products by
third-party manufacturers, by accelerating technology
innovation, creating new business relationships and solidifying
existing ones, managing cash, controlling expenses and otherwise
improving our financial performance. These awards also took into
consideration the total value of the compensation packages
awarded to our executive officers relative to those awarded to
the executive officers of other public companies in our industry.
Long-term equity compensation awards
Long-term equity compensation awards have historically been
awarded to our executive officers and other management-level
employees in the form of options to purchase shares of our
common stock. However, due to recent changes in the financial
accounting rules based on the adoption of FAS 123R, we
determined that awards of stock options should be limited
starting in 2006. Consequently, long-term equity compensation
awards for 2006 took the form of restricted shares of our common
stock.
Our Compensation Committee granted restricted share awards to
our executive officers at a meeting held on January 9,
2007. These awards will vest in equal increments of one-third
each on the next three anniversaries of the grant date. The
awards are complimentary to our annual bonus awards, and are
intended to focus executive behavior on the future of our
Company. In determining long-term equity compensation awards,
outstanding awards from prior years are considered, as are
corresponding awards to the executive officers of other public
companies similar to us in terms of market capitalization or
industry.
Special cash and non-cash awards
Under special circumstances, we have made cash and non-cash
awards to our employees, including our executive officers. For
example, we have historically awarded a small number of stock
options to our employees in connection with the filing and
issuance of patents on which they are named inventors. From time
to time, we have also issued cash awards to our employees in
connection with their having achieved special recognition in
their field or in the industry. We believe that these awards are
a small but important component of compensation intended to
recognize our employees for special individual accomplishments
that are likely to benefit us and our business.
10
In 2006, we granted options to purchase 250 shares of our
common stock to each of Mr. Seligsohn and Dr. Brown.
The grant to Mr. Seligsohn was in recognition of the
issuance of a U.S. patent for which he is a named inventor,
and the grant to Dr. Brown was in recognition of the filing
of a U.S. patent application for which she is a named
inventor. For 2006, we also issued a special cash bonus award of
$25,000 to Dr. Brown in recognition of her having been
named a Fellow of the Institute of Electrical and Electronics
Engineers.
Perquisites and other benefits
We provide benefits to all of our employees, including our
executive officers. These include paid sick and vacation time,
Company-sponsored life, short-term and long-term disability
insurance, individual and family medical and dental insurance,
401(k) plan matching contributions, and other similar benefits.
We believe that these benefits are an important factor in
helping us maintain good relations with our employees and in
creating a positive work environment.
For some of these employee benefits, the actual amount provided
depends on the employees salary, such that our
higher-salaried employees, including our executive officers,
receive total benefits that are greater than those of other
employees. For example, 401(k) plan matching contributions
amounted to $6,600 for each of our executive officers in 2006.
Although the matching contributions of our executive officers
were based on the same percentage of salary as the contributions
of other of our employees, because the salaries of our
executive officers are higher than those of our other employees,
the dollar value of those matching contributions was higher for
our executive officers. However, the difference in dollar value
is relatively small compared to the total compensation payable
to our executive officers for the year.
We also provide an automobile allowance of $500 per month
to each of Mr. Seligsohn, Mr. Abramson and
Mr. Rosenblatt. All of these individuals live a
considerable distance from our offices in Ewing, New Jersey,
such that we believe it is appropriate to partially compensate
them for their automobile usage. Again, we do not consider this
additional perquisite to be a substantial component of executive
compensation.
Stock
Ownership Guidelines
We do not have any stock ownership guidelines for our executive
officers. However, all of our executive officers are major
shareholders in the Company, and all have substantial holdings
of outstanding, vested stock options and stock purchase
warrants. We believe that these current holdings are sufficient
to ensure that our executive officers remain committed to our
Company and its business.
Change in
Control Payments
In 2003, we entered into change in control agreements with our
executive officers and other management employees. These
agreements provide for certain cash payments and other benefits
to these individuals in the event that their employment is
terminated in connection with a change in control of the
Company. They are known more commonly as
double-trigger
change-in-control
agreements. We believe that these agreements would help to
reinforce and encourage the continued attention and dedication
of these individuals to our Company in the event they are asked
to help facilitate a change in control. The specific benefits
and compensation payable to these individuals in connection with
a change in control are set forth elsewhere in this proxy
statement.
Tax and
Other Financial Consequences of Our Compensation
Program
Internal Revenue Code §162(m)
In determining the total compensation payable to our executive
officers, we considered the potential impact of
Section 162(m) of the Internal Revenue Code (the
IRC). Section 162(m) disallows any
publicly-held corporation from taking a tax deduction for
compensation in excess of $1 million paid to its executive
officers in any taxable year, unless that compensation is
performance-based. Our policy is that executive compensation
qualify for deductibility under applicable tax laws to the
extent consistent with our overall compensation objectives. For
2006, we do not believe that Section 162(m) limited the
deductibility of any compensation paid to our executive officers.
11
Internal Revenue Code §409A
Section 409A of the IRC provides that nonqualified deferred
compensation benefits are includible in an employees
income when vested, unless certain requirements are met. If
these requirements are not met, employees are also subject to an
additional income tax and interest. All of our compensation
plans and arrangements presently meet, or will be amended to
meet, these requirements. As a result, employees will be taxed
when the deferred compensation is actually paid to them, and we
will be entitled to a tax deduction at that time.
Internal Revenue Code §280G
Section 280G of the IRC disallows a companys tax
deduction for excess parachute payments.
Additionally, Section 4999 of the IRC imposes a 20% excise
tax on any person who receives excess parachute payments.
Presently, all of our executive officers are entitled to
payments upon the termination of their employment following a
change in control of the Company, some of which may qualify as
excess parachute payments. Accordingly, our tax
deduction for any such excess parachute payments would be
disallowed under Section 280G of the IRC. Moreover, we are
required to make additional payments to these individuals to
cover any excise taxes imposed on them by reason of the payments
they receive in connection with a change in control.
Accounting Treatment under FAS 123R
As previously indicated, we have modified our approach to
granting equity compensation awards due to the adoption of
FAS 123R. The adoption of this new accounting standard has
substantially increased the cost of granting stock option
awards. Consequently, we have essentially eliminated such awards
from our bonus compensation, replacing them with other forms of
equity compensation that have less of an accounting impact on
our Company.
Future
Compensation Program Considerations
As previously indicated, our Compensation Committee did not set
formal performance goals and corresponding awards for the
Companys executive officers for 2005 or 2006 due to the
early stage of the market for commercial OLED products. The
Committee has determined that market conditions remain
essentially the same, and thus has not set any performance goals
or corresponding awards for 2007. Consequently, annual and
long-term incentive awards for 2007 will again be awarded by the
Committee in its discretion at year-end, taking into account the
Companys financial results, business performance and other
relevant factors.
In 2006, our Compensation Committee directly engaged the Hay
Group, an outside global management consulting firm, to conduct
a review of compensation for members of our Board of Directors,
and to recommend an annual and long-term incentive plan for the
Companys executive officers. The Hay Groups review
of Board of Directors compensation was utilized in
determining 2006 and 2007 compensation for Board members who are
not employees or officers of the Company. The Hay Groups
recommendation of an annual and long-term incentive plan for the
Companys executive officers will be discussed further in
2007, and may be utilized to help determine executive officer
compensation for 2007 and subsequent years.
Special
Considerations for the Compensation of Our Chief Executive
Officer
The compensation of our Chief Executive Officer,
Mr. Seligsohn, has been reduced from what it otherwise
might have been to take into account that Mr. Seligsohn
also serves as Chairman of the Board of Directors and Chief
Executive Officer of, and performs services for, other companies
that he has founded. Most notable in this regard is Global
Photonic Energy Corporation (GPEC), a privately-held corporation
of which Mr. Seligsohn and his family are the largest
shareholders. We believe that this adjustment to
Mr. Seligsohns salary and other compensation is
appropriate in light of his duties and responsibilities to GPEC
and these other companies.
12
Summary
Compensation Table
The following table provides information on the compensation of
our Chief Executive Officer and our other executive officers for
services in all capacities to the Company and its subsidiary for
2006. This group is referred to in this proxy statement as the
Named Executive Officers. Values in the table are
based on the amount recognized by the Company as compensation
expense for 2006 pursuant to FAS 123R.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
All Other
|
|
|
Name and Principal Position
|
|
Salary ($)
|
|
Bonus ($)
|
|
Awards ($)
|
|
Awards ($)
|
|
Compensation ($)
|
|
Total ($)
|
|
Sherwin I. Seligsohn
|
|
|
263,796
|
|
|
|
|
|
|
|
200,000
|
(1)
|
|
|
2,338
|
(2)
|
|
|
20,564
|
(3)
|
|
|
486,698
|
|
Chairman of our Board of Directors
and Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steven V. Abramson
|
|
|
436,030
|
|
|
|
|
|
|
|
350,000
|
(4)
|
|
|
|
|
|
|
23,185
|
(5)
|
|
|
809,215
|
|
President and Chief Operating
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sidney D. Rosenblatt
|
|
|
436,030
|
|
|
|
|
|
|
|
350,000
|
(4)
|
|
|
|
|
|
|
27,220
|
(6)
|
|
|
813,250
|
|
Executive Vice President, Chief
Financial Officer, Treasurer and Secretary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Julia J. Brown, Ph.D.
|
|
|
272,657
|
|
|
|
25,000
|
|
|
|
200,000
|
(7)
|
|
|
2,239
|
(8)
|
|
|
8,508
|
(9)
|
|
|
508,404
|
|
Vice President and Chief Technical
Office
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Based on (a) 9,278 shares of Common Stock granted on
January 9, 2007, the closing price of such stock being
$14.61 on the grant date; and (b) 4,411 shares of
Common Stock withheld for payment of $64,445 of associated
payroll taxes. |
|
(2) |
|
FAS 123R grant date value of 250 options, with an exercise
price of $12.40, granted on June 20, 2006. |
|
(3) |
|
Based on (a) auto expense reimbursements of $570;
(b) life and disability insurance premium payments of
$13,394; and (c) 401(k) plan contributions of $6,600. |
|
(4) |
|
Based on (a) 14,148 shares of Common Stock granted on
January 9, 2007, the closing price of such stock being
$14.61 on the grant date; and (b) 9,808 shares of Common Stock
withheld for payment of $143,295 of associated payroll taxes. |
|
(5) |
|
Based on (a) auto expense reimbursements and allowance of
$3,957; (b) life and disability insurance premium payments
of $12,628; and (c) 401(k) plan contributions of $6,600. |
|
(6) |
|
Based on (a) auto expense reimbursements and allowance of
$2,983; (b) life and disability insurance premium payments
of $17,637; and (c) 401(k) plan contributions of $6,600. |
|
(7) |
|
Based on (a) 9,386 shares of Common Stock granted on
January 9, 2007, the closing price of such stock being
$14.61 on the grant date; and (b) 4,303 shares of Common Stock
withheld for payment of $62,871 of associated payroll taxes. |
|
(8) |
|
FAS 123R grant date value of 250 options, with an exercise
price of $11.89, granted on January 17, 2006. |
|
(9) |
|
Based on (a) life insurance premium payments of $1,908; and
(b) 401(k) plan contributions of $6,600. |
Compensation to each of the named executive officers for 2006
consisted of the following:
|
|
|
|
|
Base salary, paid in cash;
|
|
|
|
In the case of Dr. Brown, a cash bonus in recognition of
her having been named a Fellow of the Institute of Electrical
and Electronics Engineers;
|
|
|
|
Discretionary stock awards granted as 2006 performance bonuses
on January 9, 2007;
|
|
|
|
In the case of Mr. Seligsohn and Dr. Brown, stock
option awards granted as bonuses for the filing of a
U.S. patent application or the issuance of a
U.S. patent on which they are each named inventors, and
with respect to which the Company is the assignee; and
|
13
|
|
|
|
|
Perquisites in the form of auto expense reimbursements, life and
disability insurance premium payments, and 401(k) plan
contributions.
|
Grants of
Plan-Based Awards Table
The following table summarizes each grant of an award made to a
Named Executive Officers in 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
Estimated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future
|
|
|
Future
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
Payouts
|
|
|
Payouts
|
|
|
All Other
|
|
|
Option
|
|
|
|
|
|
|
|
|
|
Under
|
|
|
Under
|
|
|
Stock
|
|
|
Awards:
|
|
|
Exercise
|
|
|
|
|
|
|
Non-Equity
|
|
|
Equity
|
|
|
Awards:
|
|
|
Number of
|
|
|
or Base
|
|
|
|
|
|
|
Incentive
|
|
|
Incentive
|
|
|
Number of
|
|
|
Securities
|
|
|
Price of
|
|
|
|
|
|
|
Plan
|
|
|
Plan
|
|
|
Shares of
|
|
|
Underlying
|
|
|
Option
|
|
Name
|
|
Grant Date
|
|
|
Awards ($)
|
|
|
Awards ($)
|
|
|
Stocks (#)
|
|
|
Options (#)
|
|
|
Awards ($/Sh)
|
|
|
Sherwin I. Seligsohn
|
|
|
1/3/2006
|
|
|
|
|
|
|
|
|
|
|
|
18,281
|
(1)
|
|
|
|
|
|
|
|
|
Sherwin I. Seligsohn
|
|
|
6/20/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
|
|
12.40
|
|
Steven V. Abramson
|
|
|
1/3/2006
|
|
|
|
|
|
|
|
|
|
|
|
31,992
|
(2)
|
|
|
|
|
|
|
|
|
Sidney D. Rosenblatt
|
|
|
1/3/2006
|
|
|
|
|
|
|
|
|
|
|
|
31,992
|
(2)
|
|
|
|
|
|
|
|
|
Julia J. Brown, Ph.D.
|
|
|
1/3/2006
|
|
|
|
|
|
|
|
|
|
|
|
18,281
|
(1)
|
|
|
|
|
|
|
|
|
Julia J. Brown, Ph.D.
|
|
|
1/17/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
|
|
11.89
|
|
|
|
|
(1) |
|
Certificate was for 12,329 shares; remainder withheld to
satisfy a tax liability. |
|
(2) |
|
Certificate was for 18,793 shares; remainder withheld to
satisfy a tax liability. |
Grants of plan-based awards to each of the named executive
officers in 2006 consisted of the following:
|
|
|
|
|
Discretionary stock awards granted as 2005 performance bonuses
on January 3, 2006; and
|
|
|
|
In the case of Mr. Seligsohn and Dr. Brown, stock
option awards granted as bonuses for the filing of a
U.S. patent application or the issuance of a
U.S. patent on which they are each named inventors, and
with respect to which the Company is the assignee.
|
Outstanding
Equity Awards at Fiscal Year-End Table
The following table summarizes the outstanding equity awards to
the Named Executive Officers at the end of 2006.
Option
Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
|
|
|
|
Unexercised
|
|
|
Option
|
|
|
Option
|
|
|
|
|
|
|
Options (#)
|
|
|
Exercise
|
|
|
Expiration
|
|
Name
|
|
Grant Date
|
|
|
Exercisable
|
|
|
Price ($)
|
|
|
Date
|
|
|
Sherwin I. Seligsohn
|
|
|
6/12/1997
|
|
|
|
5,000
|
|
|
$
|
4.06
|
|
|
|
6/12/2007
|
|
|
|
|
12/17/1997
|
|
|
|
20,000
|
|
|
$
|
5.25
|
|
|
|
12/17/2007
|
|
|
|
|
12/18/1998
|
|
|
|
20,000
|
|
|
$
|
4.50
|
|
|
|
12/18/2008
|
|
|
|
|
10/12/1999
|
|
|
|
30,000
|
|
|
$
|
3.875
|
|
|
|
10/12/2009
|
|
|
|
|
12/14/2000
|
|
|
|
15,000
|
|
|
$
|
9.4375
|
|
|
|
12/14/2010
|
|
|
|
|
3/30/2001
|
|
|
|
20,000
|
|
|
$
|
10.3125
|
|
|
|
3/30/2012
|
|
|
|
|
12/17/2001
|
|
|
|
40,250
|
|
|
$
|
8.56
|
|
|
|
12/17/2012
|
|
|
|
|
9/23/2002
|
|
|
|
40,000
|
|
|
$
|
5.45
|
|
|
|
9/23/2012
|
|
|
|
|
1/24/2003
|
|
|
|
250
|
|
|
$
|
6.65
|
|
|
|
1/24/2013
|
|
|
|
|
1/20/2004
|
|
|
|
40,000
|
|
|
$
|
16.94
|
|
|
|
1/20/2014
|
|
|
|
|
1/18/2005
|
|
|
|
50,000
|
|
|
$
|
8.14
|
|
|
|
1/18/2015
|
|
|
|
|
12/30/2005
|
|
|
|
50,000
|
|
|
$
|
10.51
|
|
|
|
12/30/2015
|
|
|
|
|
6/20/2006
|
|
|
|
250
|
|
|
$
|
12.40
|
|
|
|
6/20/2016
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
|
|
|
|
Unexercised
|
|
|
Option
|
|
|
Option
|
|
|
|
|
|
|
Options (#)
|
|
|
Exercise
|
|
|
Expiration
|
|
Name
|
|
Grant Date
|
|
|
Exercisable
|
|
|
Price ($)
|
|
|
Date
|
|
|
Steven V. Abramson
|
|
|
6/12/1997
|
|
|
|
5,000
|
|
|
$
|
4.06
|
|
|
|
6/12/2007
|
|
|
|
|
12/17/1997
|
|
|
|
20,000
|
|
|
$
|
5.25
|
|
|
|
12/17/2007
|
|
|
|
|
4/2/1998
|
|
|
|
100,000
|
|
|
$
|
6.38
|
|
|
|
4/2/2008
|
|
|
|
|
12/18/1998
|
|
|
|
20,000
|
|
|
$
|
4.50
|
|
|
|
12/18/2008
|
|
|
|
|
10/12/1999
|
|
|
|
30,000
|
|
|
$
|
3.875
|
|
|
|
10/12/2009
|
|
|
|
|
12/14/2000
|
|
|
|
15,000
|
|
|
$
|
9.4375
|
|
|
|
12/14/2010
|
|
|
|
|
3/30/2001
|
|
|
|
20,000
|
|
|
$
|
10.3125
|
|
|
|
3/30/2011
|
|
|
|
|
12/17/2001
|
|
|
|
40,000
|
|
|
$
|
8.56
|
|
|
|
12/17/2011
|
|
|
|
|
9/23/2002
|
|
|
|
40,000
|
|
|
$
|
5.45
|
|
|
|
9/23/2012
|
|
|
|
|
1/20/2004
|
|
|
|
40,000
|
|
|
$
|
16.94
|
|
|
|
1/20/2014
|
|
|
|
|
1/18/2005
|
|
|
|
50,000
|
|
|
$
|
8.14
|
|
|
|
1/18/2015
|
|
|
|
|
12/30/2005
|
|
|
|
50,000
|
|
|
$
|
10.51
|
|
|
|
12/30/2015
|
|
Sidney D. Rosenblatt
|
|
|
6/12/1997
|
|
|
|
5,000
|
|
|
$
|
4.06
|
|
|
|
6/12/2007
|
|
|
|
|
12/17/1997
|
|
|
|
20,000
|
|
|
$
|
5.25
|
|
|
|
12/17/2007
|
|
|
|
|
4/2/1998
|
|
|
|
100,000
|
|
|
$
|
6.38
|
|
|
|
4/2/2008
|
|
|
|
|
12/18/1998
|
|
|
|
20,000
|
|
|
$
|
4.50
|
|
|
|
12/18/2008
|
|
|
|
|
10/12/1999
|
|
|
|
30,000
|
|
|
$
|
3.875
|
|
|
|
10/12/2009
|
|
|
|
|
12/14/2000
|
|
|
|
15,000
|
|
|
$
|
9.4375
|
|
|
|
12/14/2010
|
|
|
|
|
3/30/2001
|
|
|
|
20,000
|
|
|
$
|
10.3125
|
|
|
|
3/30/2011
|
|
|
|
|
12/17/2001
|
|
|
|
40,000
|
|
|
$
|
8.56
|
|
|
|
12/17/2011
|
|
|
|
|
9/23/2002
|
|
|
|
40,000
|
|
|
$
|
5.45
|
|
|
|
9/23/2012
|
|
|
|
|
1/20/2004
|
|
|
|
40,000
|
|
|
$
|
16.94
|
|
|
|
1/20/2014
|
|
|
|
|
1/18/2005
|
|
|
|
50,000
|
|
|
$
|
8.14
|
|
|
|
1/18/2015
|
|
|
|
|
12/30/2005
|
|
|
|
50,000
|
|
|
$
|
10.51
|
|
|
|
12/30/2015
|
|
Julia J. Brown, Ph.D.
|
|
|
6/4/1998
|
|
|
|
25,000
|
|
|
$
|
5.88
|
|
|
|
6/4/2008
|
|
|
|
|
12/18/1998
|
|
|
|
15,000
|
|
|
$
|
4.50
|
|
|
|
12/18/2008
|
|
|
|
|
10/12/1999
|
|
|
|
15,000
|
|
|
$
|
3.875
|
|
|
|
10/12/2009
|
|
|
|
|
4/18/2000
|
|
|
|
90,000
|
|
|
$
|
16.75
|
|
|
|
4/18/2010
|
|
|
|
|
6/21/2000
|
|
|
|
10,000
|
|
|
$
|
24.375
|
|
|
|
6/21/2010
|
|
|
|
|
12/14/2000
|
|
|
|
10,000
|
|
|
$
|
9.4375
|
|
|
|
12/14/2010
|
|
|
|
|
2/15/2001
|
|
|
|
250
|
|
|
$
|
10.375
|
|
|
|
2/15/2011
|
|
|
|
|
3/30/2001
|
|
|
|
20,000
|
|
|
$
|
10.3125
|
|
|
|
3/30/2011
|
|
|
|
|
4/19/2001
|
|
|
|
500
|
|
|
$
|
13.90
|
|
|
|
4/19/2011
|
|
|
|
|
12/17/2001
|
|
|
|
30,000
|
|
|
$
|
8.56
|
|
|
|
12/17/2011
|
|
|
|
|
4/15/2002
|
|
|
|
250
|
|
|
$
|
9.10
|
|
|
|
4/15/2012
|
|
|
|
|
9/23/2002
|
|
|
|
30,000
|
|
|
$
|
5.45
|
|
|
|
9/23/2012
|
|
|
|
|
11/18/2002
|
|
|
|
250
|
|
|
$
|
9.94
|
|
|
|
11/18/2012
|
|
|
|
|
6/16/2003
|
|
|
|
250
|
|
|
$
|
9.60
|
|
|
|
6/16/2013
|
|
|
|
|
1/20/2004
|
|
|
|
30,000
|
|
|
$
|
16.94
|
|
|
|
1/20/2014
|
|
|
|
|
4/20/2004
|
|
|
|
500
|
|
|
$
|
13.28
|
|
|
|
4/20/2014
|
|
|
|
|
11/23/2004
|
|
|
|
250
|
|
|
$
|
10.07
|
|
|
|
11/23/2014
|
|
|
|
|
1/18/2005
|
|
|
|
40,250
|
|
|
$
|
8.14
|
|
|
|
1/18/2015
|
|
|
|
|
6/7/2005
|
|
|
|
500
|
|
|
$
|
9.43
|
|
|
|
6/7/2015
|
|
|
|
|
12/30/2005
|
|
|
|
40,000
|
|
|
$
|
10.51
|
|
|
|
12/30/2015
|
|
|
|
|
1/17/2006
|
|
|
|
250
|
|
|
$
|
11.89
|
|
|
|
1/17/2016
|
|
15
Option
Exercises and Stock Vested Table
The following table summarizes the exercises of stock options,
SARs and other similar instruments, and the vesting of stock,
including restricted stock, restricted stock units and similar
instruments, for the Named Executive Officers during 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares
|
|
|
Value
|
|
|
Shares
|
|
|
Value
|
|
|
|
Acquired on
|
|
|
Realized on
|
|
|
Acquired on
|
|
|
Realized on
|
|
Name
|
|
Exercise (#)
|
|
|
Exercise(1)
($)
|
|
|
Vesting (#)
|
|
|
Vesting ($)
|
|
|
Sherwin I. Seligsohn
|
|
|
174,500
|
|
|
|
1,827,888
|
|
|
|
|
|
|
|
|
|
Steven V. Abramson
|
|
|
200,000
|
|
|
|
2,095,000
|
|
|
|
|
|
|
|
|
|
Sidney D. Rosenblatt
|
|
|
97,500
|
|
|
|
1,021,313
|
|
|
|
|
|
|
|
|
|
Julia J. Brown, Ph.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Based on the difference between the market price of the
underlying security at exercise and the exercise or base price
of the options. |
Potential
Payments Upon Termination or
Change-in-Control
In April 2003, the Company entered into Change in Control
Agreements with the Named Executive Officers (the CIC
Agreements). The CIC Agreements provide for certain cash
payments and other benefits to the Named Executive Officers in
the event of a termination of these individuals employment
in connection with a Change in Control of the
Company, as defined in the CIC Agreements. These benefits
include the following:
|
|
|
|
|
immediate vesting of all stock options, stock appreciation
rights, warrants, stock awards and performance units held by the
individual, whether or not restricted or subject to the
satisfaction of any performance goals or other criteria;
|
|
|
|
a lump-sum payment equal to two times the sum of the average
annual base salary and the annual bonus to the individual,
including any authorized deferrals, salary reduction amounts and
any car allowance, and including the fair market dollar value
equivalent of any bonus amounts paid in the form of stock
options, stock appreciation rights, warrants, stock awards or
performance units;
|
|
|
|
a lump-sum payment equal to the estimated after-tax cost to the
individual of continuing any Company-sponsored life or other
insurance, travel or accident insurance and disability insurance
coverage in effect for the individual, and where applicable, his
or her spouse and dependents, for two years;
|
|
|
|
to the extent permitted by law, the benefits to which the
individual would be entitled under the Companys long term
incentive, savings and retirement plans, assuming the individual
continued working for the Company for two years at his or her
annual base salary;
|
|
|
|
continued group hospitalization, health and dental care
coverage, with coverage equivalent to the coverage to which the
individual would be entitled if he or she continued working for
the Company for two years at his or her annual base salary;
|
|
|
|
outplacement assistance services for two years at a total cost
not to exceed $10,000; and
|
|
|
|
an additional payment to cover any excise tax imposed on the
individual by reason of the individual receiving the payments
and benefits specified above.
|
16
For each of the Named Executive Officers, the estimated payments
and benefits that would be provided by the Company are set forth
in the following table, based on the assumption that a
triggering event took place on December 29, 2006.
Estimated
Payments and Benefits on Termination in Connection With a
Change-in-Control
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lump
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lump
|
|
|
Sum
|
|
|
Estimated
|
|
|
After-Tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sum
|
|
|
Payment
|
|
|
Value of
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment
|
|
|
of
|
|
|
Ongoing
|
|
|
Ongoing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
for
|
|
|
Estimated
|
|
|
Contributions
|
|
|
Payments to
|
|
|
Estimated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued
|
|
|
After-Tax
|
|
|
Under
|
|
|
Continue
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
|
|
|
Lump
|
|
|
|
|
|
and
|
|
|
Cost to
|
|
|
Long-Term
|
|
|
Group
|
|
|
Unvested
|
|
|
|
|
|
Value of
|
|
|
|
|
|
|
Sum
|
|
|
Lump
|
|
|
Unused
|
|
|
Continue
|
|
|
Incentive,
|
|
|
Medical,
|
|
|
Stock
|
|
|
|
|
|
Tax
|
|
|
|
|
|
|
Payment
|
|
|
Sum
|
|
|
Paid
|
|
|
Life,
|
|
|
Savings
|
|
|
Health and
|
|
|
Options and
|
|
|
|
|
|
Reimbursement
|
|
|
|
|
|
|
of Two
|
|
|
Payment of
|
|
|
Time
|
|
|
Travel and
|
|
|
and
|
|
|
Dental
|
|
|
Stock
|
|
|
|
|
|
Payments on
|
|
|
|
|
|
|
Times
|
|
|
Two
|
|
|
Off
|
|
|
Disability
|
|
|
Retirement
|
|
|
Care
|
|
|
Awards
|
|
|
Payment for
|
|
|
Account of
|
|
|
|
|
|
|
Annual
|
|
|
Times
|
|
|
and
|
|
|
Insurance
|
|
|
Plans for
|
|
|
Coverage for
|
|
|
Subject to
|
|
|
Outplacement
|
|
|
Excise or
|
|
|
Total
|
|
|
|
Base
|
|
|
Annual
|
|
|
Sick
|
|
|
for Two
|
|
|
Two
|
|
|
Two
|
|
|
Accelerated
|
|
|
Assistance
|
|
|
Other
|
|
|
Payments and
|
|
|
|
Salary(1)
|
|
|
Bonus(2)
|
|
|
Time
|
|
|
Years
|
|
|
Years
|
|
|
Years
|
|
|
Vesting(3)
|
|
|
Services(4)
|
|
|
Taxes
|
|
|
Benefits
|
|
Name
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Sherwin I. Seligsohn
|
|
|
541,717
|
|
|
|
1,228,346
|
|
|
|
62,506
|
|
|
|
25,226
|
|
|
|
13,500
|
|
|
|
16,095
|
|
|
|
- 0 -
|
|
|
|
10,000
|
|
|
|
712,894
|
|
|
|
2,610,284
|
|
Steven V. Abramson
|
|
|
907,399
|
|
|
|
1,707,579
|
|
|
|
97,782
|
|
|
|
26,279
|
|
|
|
13,500
|
|
|
|
29,592
|
|
|
|
- 0 -
|
|
|
|
10,000
|
|
|
|
1,053,983
|
|
|
|
3,846,114
|
|
Sidney D. Rosenblatt
|
|
|
907,399
|
|
|
|
1,707,579
|
|
|
|
63,383
|
|
|
|
36,304
|
|
|
|
13,500
|
|
|
|
31,190
|
|
|
|
- 0 -
|
|
|
|
10,000
|
|
|
|
1,043,520
|
|
|
|
3,812,875
|
|
Julia J. Brown, Ph.D.
|
|
|
559,625
|
|
|
|
1,000,031
|
|
|
|
63,890
|
|
|
|
4,160
|
|
|
|
13,500
|
|
|
|
22,550
|
|
|
|
- 0 -
|
|
|
|
10,000
|
|
|
|
603,750
|
|
|
|
2,277,506
|
|
|
|
|
(1) |
|
Under the CIC Agreements, this is to be based on the highest
monthly base salary paid or payable to the employee during the
twenty-four (24) months prior to December 29, 2006,
including any amounts earned but deferred. It is also to include
any annual car allowance. For purposes of this calculation, the
employees
bi-weekly
salary as of the payment period ended on December 22, 2006
was utilized. Also, an annual car allowance of $6,000 is
included for each of Mr. Seligsohn, Mr. Abramson and
Mr. Rosenblatt. |
|
(2) |
|
Under the CIC Agreements, this is to be based on the highest
annual bonus to the employee for the last three full fiscal
years prior to December 29, 2006, and is to include the
fair market dollar value equivalent of any stock, restricted
stock or stock options issued as bonus consideration, determined
as of the date of issuance and without regard to any
restrictions or vesting conditions. For purposes of this
calculation, the employees 2003 annual bonus was utilized. |
|
(3) |
|
Assumes all unvested or restricted stock options and stock
awards automatically vest on a change of control. Does not
include restricted stock bonuses awarded on January 9, 2007. |
|
(4) |
|
The maximum amount payable for outplacement assistance services
is $10,000. |
In consideration of receiving these payments and benefits, each
Named Executive Officer has agreed not to compete with the
Company for six months following his or her termination in
connection with a change in control of the Company. Each Named
Executive Officer has further agreed that, for two years
following his or her termination he or she will not knowingly
(i) solicit or recruit any of the Companys employees
to compete with the Company, or (ii) divert or unreasonably
interfere with the Companys business relationships with
any of its suppliers, customers, partners or joint venturers
with whom the individual had any involvement. In addition, each
Named Executive Officer is required to execute a general release
of all employment-related claims he or she may have against the
Company in order to receive the payments and benefits specified
under the CIC Agreement.
As used in the CIC Agreement, a change in control of the Company
would occur if:
|
|
|
|
|
any person first becomes the beneficial owner of securities of
the Company (not including securities previously owned by such
persons or any securities acquired directly from the Company)
representing 30% or more of the then-outstanding voting
securities of the Company;
|
|
|
|
the individuals who constitute our Board of Directors at the
beginning of any
24-month
period cease, for any reason other than death, to constitute at
least a majority of our Board of Directors;
|
|
|
|
the Company consummates a merger or consolidation with any other
corporation, except where the voting securities of the Company
outstanding immediately prior to the merger or consolidation
continue to represent at least 50% of the voting securities of
the Company (or the surviving entity of the merger or
|
17
|
|
|
|
|
consolidation or its parent), or where no person first becomes
the beneficial owner of securities of the Company representing
30% or more of the then-outstanding voting securities of the
Company;
|
|
|
|
|
|
the shareholders of the Company approve a plan of complete
liquidation or dissolution of the Company, or an agreement is
consummated for the sale or disposition by the Company of all or
substantially all of its assets, excluding a sale or disposition
by the Company of all or substantially all of its assets to an
entity, at least 50% of the voting securities of which are owned
by persons in substantially the same proportion as their
ownership of the Company immediately prior to the sale; or
|
|
|
|
any person consummates a tender offer or exchange for a majority
of the voting securities of the Company.
|
As used in the CIC Agreement, a termination of a Named Executive
Officer in connection with a change in control of the Company
would include a termination of the individuals employment:
|
|
|
|
|
by the Company within two years after a change in control of the
Company other than for the individuals death or
incapacity, or for cause;
|
|
|
|
by the individual within two years after a change in control of
the Company for (i) any significant reduction by the
Company of the individuals authority, duties or
responsibilities, (ii) any demotion or removal of the
individual from his or her employment grade, compensation level
or officer positions, (iii) any requirement that individual
undertake business travel to an extent substantially greater
than is reasonable and customary for his or her position,
(iv) a relocation by more than 25 miles of the offices
of the Company at which the individual principally works,
(v) the Companys breach of the CIC Agreement, or
(vi) a failure of the Company to obtain an agreement from
any successor to assume the Companys obligations under the
CIC Agreement; and
|
|
|
|
by either the Company or the individual during the one year
period prior to a change in control of the Company, unless the
Company establishes by clear and convincing evidence that the
termination was for good faith business reasons not related to
the change in control.
|
Compensation
of Directors
The following table provides information on the compensation of
members of our Board of Directors (who are not Named Executive
Officers) for 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
or Paid
|
|
|
Stock
|
|
|
Option
|
|
|
All Other
|
|
|
|
|
|
|
in Cash
|
|
|
Awards(1)
|
|
|
Awards(1)
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Leonard Becker
|
|
|
40,000
|
|
|
|
62,400
|
(2)
|
|
|
|
|
|
|
|
|
|
|
102,400
|
|
Elizabeth H. Gemmill
|
|
|
40,000
|
|
|
|
62,400
|
(2)
|
|
|
|
|
|
|
|
|
|
|
102,400
|
|
C. Keith Hartley
|
|
|
40,000
|
|
|
|
62,400
|
(2)
|
|
|
|
|
|
|
|
|
|
|
102,400
|
|
Lawrence Lacerte
|
|
|
40,000
|
|
|
|
62,400
|
(2)
|
|
|
|
|
|
|
|
|
|
|
102,400
|
|
|
|
|
(1) |
|
The aggregate numbers of shares issuable to each director upon
the exercise of options outstanding as of December 31, 2006
were as follows: Mr. Becker
130,000 shares; Ms. Gemmill
145,000 shares; Mr. Hartley
130,000 shares; and Mr. Lacerte
25,000 shares. There were no stock awards to any of our
directors outstanding as of December 31, 2006. |
|
(2) |
|
Grant date fair value of 5,000 shares issued as
compensation for 2006, the grant date price being
$12.48 per share. |
Compensation to each member of the Board of Directors for 2006
consisted of the following:
|
|
|
|
|
Director fees, paid in cash; and
|
|
|
|
Stock awards granted on December 19, 2006.
|
18
Committee chairpersons did not receive any additional fees or
other compensation for service in this capacity. In addition to
the foregoing amounts, we reimbursed members of our Board of
Directors for their reasonable travel expenses to attend all
Board and committee meetings in 2006.
PROPOSAL 2
RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE
COMPANYS
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2007
At its March 12, 2007 meeting, our Audit Committee
recommended and approved the appointment of KPMG LLP
(KPMG) as the Companys independent registered
public accounting firm (our independent auditors) to examine the
consolidated financial statements of the Company for the year
ending December 31, 2007. KPMG has served in this capacity
since being engaged by us on July 30, 2002. We are seeking
the ratification of our appointment of KPMG as our independent
auditors for 2007 at the Annual Meeting of Shareholders.
We expect that a representative of KPMG will be present at the
Annual Meeting and will be available to respond to appropriate
questions. If this representative desires to do so, he or she
will have the opportunity to make a statement at the Annual
Meeting.
Vote
Required and Recommendation of our Board of Directors
This proposal will be approved if a majority of the votes cast
by all shareholders, voting as a single class, are FOR approval.
Abstentions on this proposal are not considered votes
cast and will have no effect on the outcome of the vote.
Similarly, broker non-votes are not considered votes
cast with respect to this proposal and, therefore, will
have no effect on the outcome of the vote.
THE BOARD
OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR
ADOPTION OF THIS PROPOSAL.
Fees
Billed by the Companys Independent Auditors
The audit and tax fees billed to us by KPMG for 2006 and 2005
are set forth in the table below:
|
|
|
|
|
|
|
|
|
Fee Category
|
|
2006
|
|
|
2005
|
|
|
Audit
Fees(1)
|
|
$
|
185,000
|
(1)
|
|
$
|
179,500
|
(1)
|
Audit-Related Fees
|
|
|
|
|
|
|
|
|
Tax Fees
|
|
|
|
|
|
$
|
30,518
|
(2)
|
All Other Fees
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Consisted of fees relating to the audit of consolidated
financial statements, the audit of internal control over
financial reporting, quarterly reviews and the issuances of
consents. |
|
(2) |
|
Consisted of fees relating to services performed to analyze
U.S. and foreign tax consequences associated with various
licensing and other transactions. |
Audit
Committee Pre-Approval Policies and Procedures
Our Audit Committee currently approves all engagements to
provide both audit and non-audit services, and has not
established formal pre-approval policies or procedures. During
2006, our Audit Committee did not approve any non-audit
services, as defined by
Rule 2-01(c)(7)(i)(C)
of
Regulation S-X.
19
EQUITY
COMPENSATION PLANS
The following table includes information on our equity
compensation plans (including individual compensation
arrangements), both those previously approved and not approved
by our shareholders, as of December 31, 2006:
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities
|
|
|
|
|
|
|
|
|
|
to be issued upon
|
|
|
Weighted-average
|
|
|
Number of securities
|
|
|
|
exercise of
|
|
|
exercise price of
|
|
|
remaining available for
|
|
|
|
outstanding options,
|
|
|
outstanding options,
|
|
|
future issuance under
|
|
Plan Category
|
|
warrants and rights
|
|
|
warrants and rights
|
|
|
equity compensation
plans(1)
|
|
|
Equity compensation plans approved
by security holders
|
|
|
3,743,592
|
|
|
$
|
9.51
|
|
|
|
1,655,248
|
|
Equity compensation plans not
approved by security holders
|
|
|
2,324,557
|
(2)
|
|
$
|
13.58
|
|
|
|
|
|
Total
|
|
|
6,068,149
|
|
|
$
|
11.07
|
|
|
|
1,655,248
|
|
|
|
|
(1) |
|
Excludes securities reflected in the column entitled
Number of securities to be issued upon exercise of
outstanding options, warrants and rights. |
|
(2) |
|
Equity compensation plan arrangements not approved by
shareholders consist of various warrants to purchase shares of
our common stock. These warrants were granted under written
agreements containing substantially similar terms. The material
distinguishing features of each such arrangement are identified
in the table below. Where there were multiple grantees, the
number of individual grantees is noted next to the grantee name.
All grants are fully vested. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Unexercised
|
|
|
Exercise
|
|
|
|
|
|
|
|
Grantee(s)
|
|
Shares
|
|
|
Price
|
|
|
Grant Date
|
|
|
Expiration Date
|
|
|
Princeton University and the
University of Southern California
|
|
|
52,217
|
(a)
|
|
$
|
7.25
|
|
|
|
10/9/1997
|
|
|
|
10/9/2007
|
|
Steven V. Abramson
|
|
|
100,000
|
|
|
$
|
6.38
|
|
|
|
4/2/1998
|
|
|
|
4/2/2008
|
|
Sidney D. Rosenblatt
|
|
|
100,000
|
|
|
$
|
6.38
|
|
|
|
4/2/1998
|
|
|
|
4/2/2008
|
|
Scientific Advisory Board
Members 2
|
|
|
117,412
|
|
|
$
|
6.38
|
|
|
|
4/2/1998
|
|
|
|
4/2/2008
|
|
Consultant/Agent
|
|
|
25,000
|
|
|
$
|
7.00
|
|
|
|
4/2/1998
|
|
|
|
4/2/2008
|
|
Consultant/Agent
|
|
|
25,000
|
|
|
$
|
7.25
|
|
|
|
6/30/1998
|
|
|
|
6/30/2008
|
|
Scientific Advisory Board
Members 2
|
|
|
227,988
|
(b)
|
|
$
|
12.39
|
(b)
|
|
|
2/17/2000
|
|
|
|
2/17/2010
|
|
Julia J. Brown, Ph.D.
|
|
|
90,000
|
|
|
$
|
16.75
|
|
|
|
4/18/2000
|
|
|
|
4/18/2010
|
|
Motorola, Inc.
|
|
|
150,000
|
|
|
$
|
21.60
|
|
|
|
9/29/2000
|
|
|
|
9/29/2007
|
|
Consultant/Agent
|
|
|
189,132
|
(b)
|
|
$
|
17.13
|
(b)
|
|
|
9/29/2000
|
|
|
|
9/29/2007
|
|
PPG Industries, Inc.
|
|
|
28,168
|
|
|
$
|
24.28
|
|
|
|
2/15/2001
|
|
|
|
2/15/2008
|
|
Gerard Klauer Mattison &
Co., Inc.
|
|
|
186,114
|
(a)
|
|
$
|
13.51
|
(b)
|
|
|
8/22/2001
|
|
|
|
8/22/2008
|
|
PPG Industries, Inc.
|
|
|
121,843
|
|
|
$
|
24.28
|
|
|
|
2/15/2002
|
|
|
|
2/15/2009
|
|
PPG Industries, Inc.
|
|
|
361,024
|
|
|
$
|
10.14
|
|
|
|
2/15/2003
|
|
|
|
2/15/2010
|
|
SG Cowen Securities Corporation
|
|
|
50,313
|
(a)
|
|
$
|
8.00
|
|
|
|
8/28/2003
|
|
|
|
8/28/2008
|
|
PPG Industries, Inc.
|
|
|
315,461
|
|
|
$
|
10.39
|
|
|
|
2/15/2004
|
|
|
|
2/15/2011
|
|
PPG Industries, Inc.
|
|
|
184,885
|
|
|
$
|
24.28
|
|
|
|
2/15/2005
|
|
|
|
2/15/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total warrants and options
not
approved by security holders
|
|
|
2,324,557
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
All or a portion of these warrant shares have been transferred
by the original grantee(s) to one or more third parties. |
|
(b) |
|
As adjusted, in accordance with anti-dilution provisions of the
applicable warrant agreements. |
20
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Security
Ownership of Certain Beneficial Owners
The table below sets forth certain information, as of the Record
Date, with respect to persons known by the Company to
beneficially own more than five percent (5%) of any class of our
voting securities.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
Percentage
|
|
Title of Class
|
|
Name and Address of Beneficial
Owner(1)
|
|
Beneficially
Owned(2)
|
|
|
Ownership(2)
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott
Seligsohn(3)(4)
|
|
|
3,437,186
|
|
|
|
10.8
|
%
|
|
|
Lori S.
Rubenstein(3)(5)
|
|
|
3,301,000
|
|
|
|
10.4
|
%
|
|
|
Steven G.
Winters(3)(6)
|
|
|
3,176,000
|
|
|
|
10.0
|
%
|
|
|
FMR
Corp.(7)
|
|
|
3,125,430
|
|
|
|
9.9
|
%
|
|
|
Edward C. Johnson
3d(7)
|
|
|
3,125,430
|
|
|
|
9.9
|
%
|
Series A Preferred
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
American Biomimetics
Corporation(6)(8)
|
|
|
200,000
|
|
|
|
100
|
%
|
|
|
Sherwin I.
Seligsohn(8)
|
|
|
200,000
|
|
|
|
100
|
%
|
|
|
|
(1) |
|
Unless otherwise indicated, the address of each beneficial owner
is 375 Phillips Boulevard, Ewing, New Jersey 08618. |
|
(2) |
|
Unless otherwise indicated, we believe that all persons named in
the table have sole voting and investment power with respect to
all shares of our common stock and Series A Preferred Stock
beneficially owned by them. The percentage ownership for each
beneficial owner listed above is based on 31,706,385 shares
of our common stock and 200,000 shares of our Series A
Preferred Stock outstanding as of the Record Date. In accordance
with SEC rules, options or warrants to purchase shares of our
common stock that were exercisable as of the Record Date, or
would become exercisable within 60 days thereafter, are
deemed to be outstanding and beneficially owned by the person
holding such options or warrants for the purpose of computing
such persons percentage ownership, but are not deemed to
be outstanding for the purpose of computing the percentage
ownership of any other person. |
|
(3) |
|
Includes (i) 1,500,000 shares of our common stock
owned by the Sherwin I. Seligsohn Irrevocable Indenture of Trust
dated July 29, 1993, FBO Lori S. Rubenstein (the
Rubenstein Trust), of which Lori S. Rubenstein,
Scott Seligsohn and Steven G. Winters are co-trustees;
(ii) 1,500,000 shares of our common stock owned by the
Sherwin I. Seligsohn Irrevocable Indenture of Trust dated
July 29, 1993, FBO Scott Seligsohn (the Seligsohn
Trust), of which Lori S. Rubenstein, Scott Seligsohn and
Steven G. Winters are co-trustees; and
(iii) 176,000 shares of our common stock owned by
American Biomimetics Corporation, of which the Rubenstein Trust
and Seligsohn Trust are the principal shareholders.
Ms. Lori S. Rubenstein is Mr. Sherwin I.
Seligsohns adult daughter, and Mr. Scott Seligsohn is
Mr. Sherwin I. Seligsohns adult son. |
|
(4) |
|
Includes 68,250 options to purchase shares of our common stock
and 192,936 shares of our common stock owned directly by
Mr. Scott Seligsohn. |
|
(5) |
|
Includes 125,000 shares of our common stock owned directly
by Ms. Rubenstein. |
|
(6) |
|
The address of these beneficial owners is c/o Wolf, Block,
Schorr and Solis-Cohen LLP, 1650 Arch Street,
22nd Floor,
Philadelphia, PA 19103. |
|
(7) |
|
Based solely on a Schedule 13G/A filed by FMR Corp. and
Edward C. Johnson 3d, Chairman of FMR Corp., on
February 14, 2007. These shares are beneficially owned by
Fidelity Management & Research Company
(Fidelity), a wholly-owned subsidiary of FMR Corp.
and a registered investment advisor. Fidelity has sole power to
dispose of or to direct the disposition of all
3,125,430 shares, but does not have sole or shared power to
vote or to direct the vote of any of the shares. The ownership
of one investment company, Fidelity Growth Company Fund,
amounted to 3,123,830 of the shares. Neither FMR Corp. nor
Edward C. Johnson 3d has the sole power to vote or direct the
voting of shares owned directly by the Fidelity Funds, which
power resides with the Funds Board of Trustees. Fidelity
carries out the voting of the shares under written guidelines
established |
21
|
|
|
|
|
by the Funds Board of Trustees. The address of each of
Fidelity Management & Research Company, FMR Corp.,
Fidelity Growth Company Fund and Edward C. Johnson 3d is 82
Devonshire Street, Boston, Massachusetts 02109. |
|
(8) |
|
Mr. Sherwin I. Seligsohn, our Chairman of the Board and
Chief Executive Officer, is the sole Director, Chairman,
President and Secretary of American Biomimetics Corporation,
which owns all 200,000 shares of our Series A
Preferred Stock. |
Security
Ownership of Management
The table below sets forth certain information, as of the Record
Date, with respect to the beneficial ownership of any class of
our equity securities beneficially owned by all directors,
nominees for director and Named Executive Officers of the
Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
Percentage
|
|
Title of Class
|
|
Name and Address of Beneficial
Owner(1)
|
|
Beneficially
Owned(2)
|
|
|
Ownership(2)
|
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
Sherwin I.
Seligsohn(3)
|
|
|
710,979
|
|
|
|
2.2
|
%
|
|
|
Steven V. Abramson
|
|
|
684,063
|
|
|
|
2.1
|
%
|
|
|
Sidney D. Rosenblatt
|
|
|
589,709
|
|
|
|
1.8
|
%
|
|
|
Julia J. Brown, Ph.D.
|
|
|
402,185
|
|
|
|
1.3
|
%
|
|
|
Leonard Becker
|
|
|
205,750
|
|
|
|
*
|
|
|
|
Elizabeth H. Gemmill
|
|
|
169,250
|
|
|
|
*
|
|
|
|
C. Keith
Hartley(4)
|
|
|
181,278
|
|
|
|
*
|
|
|
|
Lawrence Lacerte
|
|
|
826,250
|
|
|
|
2.6
|
%
|
|
|
All directors and executive
officers as a group (8 persons)
|
|
|
3,769,464
|
|
|
|
11.2
|
%
|
Series A Preferred
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
Sherwin I.
Seligsohn(5)
|
|
|
200,000
|
|
|
|
100
|
%
|
|
|
|
* |
|
Represents less than 1% of our outstanding common stock. |
|
(1) |
|
Unless otherwise indicated, the address of each beneficial owner
is 375 Phillips Boulevard, Ewing, New Jersey 08618. |
|
(2) |
|
Unless otherwise indicated, we believe that all persons named in
the table have sole voting and investment power with respect to
all shares of our common stock beneficially owned by them. The
percentage ownership for each beneficial owner listed above is
based on 31,706,385 shares of our common stock and
200,000 shares of our Series A Preferred Stock
outstanding as of the Record Date. In accordance with SEC rules,
options or warrants to purchase shares of our common stock that
were exercisable as of the Record Date, or would become
exercisable within 60 days thereafter, are deemed to be
outstanding and beneficially owned by the person holding such
options or warrants for the purpose of computing such
persons percentage ownership, but are not deemed to be
outstanding for the purpose of computing the percentage
ownership of any other person. The numbers of shares of common
stock listed include the following number of shares issuable
upon the exercise of outstanding warrants or options: Sherwin I.
Seligsohn 330,750; Steven V. Abramson
430,000; Sidney D. Rosenblatt 430,000; Julia J.
Brown 358,500; Leonard Becker 130,000;
Elizabeth H. Gemmill 145,000; C. Keith
Hartley 130,000; and Lawrence Lacerte
25,000. |
|
(3) |
|
Includes 176,000 shares of our common stock owned by
American Biomimetics Corporation, of which Mr. Sherwin I.
Seligsohn is the sole Director, Chairman, President and
Secretary. Also includes 21,000 shares of our common stock
owned by The Seligsohn Foundation, of which Mr. Sherwin I.
Seligsohn is the sole trustee. Does not include
(i) 1,500,000 shares of our common stock owned by the
Rubenstein Trust; (ii) 1,500,000 shares of our common
stock owned by the Seligsohn Trust;
(iii) 125,000 shares of our common stock owned by
Ms. Lori S. Rubenstein; and (iv) 68,250 options to
purchase shares of our common stock and 192,936 shares of
our common stock owned by Mr. Scott Seligsohn, as to which
in each case Mr. Sherwin I. Seligsohn disclaims beneficial
ownership. |
22
|
|
|
(4) |
|
Includes 23,528 shares of our common stock owned by
Mr. Hartleys Defined Benefit Pension Plan. |
|
(5) |
|
Mr. Sherwin I. Seligsohn is the sole Director, Chairman,
President and Secretary of American Biomimetics Corporation,
which owns all 200,000 shares of our Series A
Preferred Stock. |
CERTAIN
TRANSACTIONS WITH RELATED PERSONS
Our
Relationship with Global Photonic Energy Corporation
Global Photonic Energy Corporation (GPEC) is a
private company that was formed by Sherwin I. Seligsohn, our
Chairman of the Board and Chief Executive Officer, at about the
same time the Company was founded in 1994. GPECs business
focuses on organic photovoltaic solar cells and
photoelectrolysis technologies. GPECs organic photovoltaic
technologies are related to the Companys organic light
emitting device (OLED) technologies, in that similar processes
and materials used to emit light from an OLED may be useful for
converting solar energy into electricity in an organic
photovoltaic device.
Sherwin I. Seligsohn currently serves as Chairman of the Board,
Chief Executive Officer and President of GPEC. Certain other of
our employees who are not directors or executive officers of the
Company also are employed by
and/or serve
on the Board of Directors of GPEC. Mr. Seligsohn and these
other individuals receive separate salaries, bonuses and other
compensation from GPEC for their work in these various
capacities.
The Company leases to GPEC, on a
month-to-month
basis, approximately 556 square feet of space (constituting
three offices) at the Companys Ewing, New Jersey facility.
The Company also permits GPEC employees to reasonably access and
use other areas of the facility, and to utilize associated
utilities and other ancillary services (telephone services,
computer printer services, photocopying services, Internet
access, computer backup, etc.) as required in connection with
GPECs occupancy of the leased office space. GPEC pays the
Company $18.50 per square foot per year for use of the leased
office space, plus an additional $109.50 per month for
associated utilities and other ancillary services. For 2006,
payments from GPEC for these purposes totaled $11,600.
The Company also subleases to GPEC one-half of the
850 square feet of office space leased by the Company in
Coeur dAlene, Idaho. Two shared employees of the Company
and GPEC work at this facility. GPEC pays the Company
$400 per month for this leased space, which is one-half of
the amount paid by the Company under the lease, including all
rent and utilities. For 2006, payments from GPEC for this leased
space totaled $4,350.
For many years, the Company and GPEC have both funded research
in the laboratories of Dr. Stephen R. Forrest, formerly at
Princeton University and now at the University of Michigan, and
Dr. Mark E. Thompson at the University of Southern
California. The Companys funded research relates to OLEDs
and other organic opto-electronic devices, and GPECs
funded research relates to organic photovoltaic solar cells. On
occasion, inventions arising from this funded research have
application to both the Companys and GPECs fields of
interest.
To address this potential overlap of interest, the Company and
GPEC reached an understanding, memorialized in a letter dated
June 4, 2004, that patent rights derived from research
funded under the research agreements after that date would be
censed to each of the Company and GPEC exclusively in its
respective field of interest. For GPEC, this field is organic
photovoltaic cell for solar energy conversion. For the Company,
this field is thin film organic electronics for displays,
lasers, lighting, organic tfts, organic memories and other
thin-film organic devices, but not including thin film organic
photovoltaic cells for solar energy conversion. The Company has
agreed to pay 75% and GPEC has agreed to pay 25% of the legal
fees and other costs for patent filings claiming inventions that
have application to both parties fields of interest, which
filings are made in agreed upon countries. If only one of the
parties wishes to make a patent filing in a particular country,
that party bears the entire cost of the filing. Otherwise, the
parties exchange no money or other consideration on account of
this arrangement.
Our
Relationship with Scott Seligsohn
We employ Scott Seligsohn, son of Sherwin I. Seligsohn, as an
executive assistant to Sherwin I. Seligsohn in his capacity as
our Chief Executive Officer and Chairman of our Board of
Directors. For 2006, we paid Scott Seligsohn base salary and
bonus compensation of $96,020. On June 20, 2006, we also
issued to Scott Seligsohn options to purchase
250 shares of our common stock as a bonus for the issuance
of a U.S. patent on which he was a
23
named inventor, and with respect to which the Company is the
assignee. These options have an exercise price of
$12.40 per share, and the exercise period is 10 years
from the date of issuance.
On March 30, 2006, Scott Seligsohn exercised warrants to
purchase 200,000 shares of our common stock that were
issued to him as employment compensation on April 25, 1996.
These warrants had an exercise price of $4.125 per share,
and the exercise period was 10 years from the date of
issuance. The value of these warrants on the date of exercise,
as determined based on the difference between the market price
of our common stock on that date and the exercise price of the
warrants, was $2,095,000. Upon exercising these warrants,
Scott Seligsohn received 85,065 shares of our common
stock, which he continues to own. Of the remaining warrant
shares, 57,935 shares were withheld by the Company to
satisfy a tax liability that the Company paid on
Scott Seligsohns behalf, and 57,000 shares were
sold by Scott Seligsohn under an effective resale
registration statement on
Form S-3
to satisfy an additional tax liability of Scott Seligsohn
that arose from the transaction.
Outstanding
Warrant Exercise by C. Keith Hartley
On January 6, 2006, C. Keith Hartley, a member of our Board
of Directors, exercised warrants to purchase 4,000 shares
of our common stock that were issued to him on January 8,
2001 as a finders fee in connection with a private
placement transaction we consummated in December 2000. These
warrants had an exercise price of $10.00 per share, and the
exercise period was five years from the date of issuance. The
value of these warrants on the date of exercise, as determined
based on the difference between the market price of our common
stock on that date and the exercise price of the warrants, was
$5,880. Upon exercising these warrants, Mr. Hartley
received 4,000 shares of our common stock, which he still
currently owns.
Policies
and Procedures for Approval of Related Person
Transactions
Consistent with applicable NASDAQ listing requirements, the
Audit Committee of our Board of Directors is responsible for
reviewing all transactions between the Company and related
persons for potential conflicts of interest on an ongoing basis,
and for approving all such transactions. Related persons include
any of our directors or nominees for director, any of our
executive officers, any shareholders owning more than 5% of any
class of our equity securities, and immediate family members of
any of these persons.
To help identify transactions with related persons, each year,
we submit and require our directors and executive officers to
complete Director and Officer Questionnaires identifying any
transactions with us in which they or their family members have
an interest. Responses to these Director and Officer
Questionnaires are reviewed and transactions that might
reasonably pose a conflict of interest are brought to the
attention of the Audit Committee for consideration.
The transactions with related persons identified above were all
reviewed with our Audit Committee at a meeting on April 17,
2007. At this meeting, the Audit Committee ratified each of
these transactions following its consideration of the potential
conflicts of interest.
SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires our executive
officers and directors, as well as persons beneficially owning
more than 10% of any class of our equity securities, to file
with the SEC reports of beneficial ownership and reports of
changes in beneficial ownership of these equity securities.
Based solely on our review of these reports as furnished to us
during or with respect to 2006, we believe that our executive
officers, directors and holders of more than 10% of any class of
our equity securities met all applicable filing requirements,
except for one Form 4 filing for Lawrence Lacerte that was
submitted three business days late.
ETHICS
AND BUSINESS CONDUCT
Code of
Ethics and Code of Conduct for Employees
We have adopted Corporate Policies and Procedures applicable to
all of our officers and other employees, which we updated in
December 2006 and which was ratified by our Board of Directors
on January 15, 2007. A
24
portion of these policies and procedures (our Code of
Conduct for Employees) constitutes our code of
ethics for the Chief Executive Officer, Chief Financial
Officer and Controller within the meaning of applicable SEC
rules. Our Code of Conduct for Employees also serves as our
code of conduct applicable to all officers and
employees of the Company as required by applicable NASDAQ
listing standards. Our Code of Conduct for Employees is publicly
available through the For Investors section of our
website at http://www.universaldisplay.com.
If we make any further amendments to our Code of Conduct for
Employees (other than technical, administrative, or other
non-substantive amendments), or if we grant any waivers of the
Code of Conduct for Employees (including implicit waivers) in
favor our Chief Executive Officer, Chief Financial Officer or
Controller, we will disclose the nature of the amendment or
waiver, its effective date and to whom it applies in that same
location on our website, or in a current report on
Form 8-K
that we file with the SEC. In addition, any waiver of our Code
of Conduct for Employees with respect to our executive officers
must be approved by our Board of Directors.
Code of
Conduct for Directors
Our Board of Directors has adopted a Code of Conduct for
Directors that serves as our code of conduct
applicable to all of our directors as required by applicable
NASDAQ listing requirements. Our Code of Conduct for Directors
is publicly available through the For Investors
section of our website at
http://www.universaldisplay.com. Any waiver of our Code
of Conduct for Directors must be approved by our Board of
Directors and will be disclosed as required under applicable
regulations.
SHAREHOLDER
PROPOSALS
Shareholders may submit proposals to us on matters appropriate
for shareholder action at our next annual meeting of
shareholders in accordance with regulations adopted by the SEC.
Proposals must be received by December 26, 2007, to be
considered for inclusion in the proxy statement and form of
proxy for our next annual meeting of shareholders. Shareholder
proposals received by us after March 10, 2008, will be
deemed untimely, and proxy holders will have the
right to exercise discretionary voting authority with respect to
such proposals.
All shareholder proposals must be in writing and must comply
with the notice, information and consent provisions contained in
our Amended and Restated Bylaws. Proposals should be directed to
the attention of our Corporate Secretary at Universal Display
Corporation, 375 Phillips Boulevard, Ewing, New Jersey 08618.
ANNUAL
REPORT TO SHAREHOLDERS
A copy of our 2006 Annual Report, containing financial
statements for the year ended December 31, 2006, is being
transmitted with this proxy statement. A copy of our Annual
Report on
Form 10-K
for the year ended December 31, 2006, including the
financial statements and any financial statement schedules, may
be obtained, without charge, by writing to us at Universal
Display Corporation, 375 Phillips Boulevard, Ewing, New Jersey
08618, Attn: Corporate Secretary.
Sidney D. Rosenblatt
Executive Vice President, Chief Financial Officer,
Treasurer and Secretary
Ewing, New Jersey
April 27, 2007
25
Appendix A
UNIVERSAL DISPLAY CORPORATION
PROXY FOR THE ANNUAL MEETING OF SHAREHOLDERS ON JUNE 21, 2007
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Sherwin I. Seligsohn, Steven V. Abramson and Sidney D. Rosenblatt,
jointly and severally, as proxies, each with power to appoint a substitute, and hereby authorizes
them to represent and to vote, as designated on the reverse side, all of the shares of common stock
of Universal Display Corporation held of record by the undersigned on April 13, 2007, at the Annual
Meeting of Shareholders to be held on June 21, 2007, or any adjournment thereof.
PLEASE COMPLETE AND SIGN THIS PROXY ON THE REVERSE SIDE AND RETURN YOUR PROXY PROMPTLY
(Continued and to be signed on the reverse side)
A-1
THE
BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE ELECTION OF
DIRECTORS
AND FOR PROPOSAL 2.
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.
PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE [X]
1. |
|
Election of the seven directors proposed in the accompanying Proxy Statement, each to serve
for a one-year term and until a successor is selected and qualified. |
|
|
|
|
|
|
|
|
|
|
|
|
|
NOMINEES |
|
|
|
|
|
|
|
[ ]
|
|
FOR ALL NOMINEES
|
|
o
|
|
Steven V. Abramson |
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Leonard Becker |
|
|
|
|
|
|
|
[ ]
|
|
WITHHOLD AUTHORITY
|
|
o
|
|
Elizabeth H. Gemmill |
|
|
FOR ALL NOMINEES |
|
|
|
|
|
|
|
|
o
|
|
C. Keith Hartley |
|
|
|
|
|
|
|
[ ]
|
|
FOR ALL EXCEPT
|
|
o
|
|
Lawrence Lacerte |
|
|
(See Instructions Below) |
|
|
|
|
|
|
|
|
o
|
|
Sidney D. Rosenblatt |
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Sherwin I. Seligsohn |
|
|
|
INSTRUCTION: |
|
To withhold authority to vote for any individual nominee(s), mark FOR ALL
EXCEPT and fill in the circle next to each nominee you wish to withhold, as shown here: n |
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR |
|
AGAINST |
|
ABSTAIN |
|
|
|
|
|
|
|
|
|
2.
|
|
Ratification of the Appointment of KPMG
LLP as the Companys Independent Registered
Public Accounting Firm for 2007
|
|
o
|
|
o
|
|
o |
The shares represented by this proxy, if it is properly executed, will be voted in the manner
directed herein by the undersigned shareholder(s). If no direction is made, the shares represented
by this proxy will be voted FOR all nominees for director and FOR Proposal 2. To the extent
permissible under applicable law, this proxy also delegates discretionary authority to vote on any
matter that may properly come before the meeting, or any adjournment or postponement thereof.
|
|
|
|
To change the address on your account, please check the box at right
and indicate your new address in the address space above. Please note
that changes to the registered name(s) on the account may not be
submitted via this method.
|
|
o |
Signature of Shareholder:
Date
Signature of Shareholder:
Date
Note: Please sign exactly as your name or names appear on this Proxy. When shares are held
jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or
guardian, please give full title as such. If the signer is a corporation, please sign full
corporate name by duly authorized officer, giving full title as such. If signer is a partnership,
please sign in partnership name by authorized person.
A-2